Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


10.06.2024

3 Aliment Pharmacol Ther
1 BMC Gastroenterol
1 Dig Dis Sci
1 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
2 Gut
10 Inflamm Bowel Dis
1 J Clin Gastroenterol
7 J Crohns Colitis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. GARCIA MJ, Gisbert JP, Chaparro M
    Letter: Third-line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions-Authors' reply.
    Aliment Pharmacol Ther. 2024 Jun 6. doi: 10.1111/apt.18104.
    PubMed        

  2. STRANDE V, Lund C, Hagen M, Bengtson MB, et al
    Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort.
    Aliment Pharmacol Ther. 2024 Jun 4. doi: 10.1111/apt.18097.
    PubMed         Abstract available

  3. CHETWOOD JD, Ding NS
    Letter: Third-line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions.
    Aliment Pharmacol Ther. 2024 Jun 3. doi: 10.1111/apt.18056.
    PubMed        


    BMC Gastroenterol

  4. TANAKA M, Kawakami A, Sakagami K, Terai T, et al
    Development and validation of a 13-item short version of the inflammatory bowel disease self-efficacy scale.
    BMC Gastroenterol. 2024;24:190.
    PubMed         Abstract available


    Dig Dis Sci

  5. BARNES A, Mukherjee S, Andrews JM, Spizzo P, et al
    Active Inflammatory Bowel Disease Is Associated with Short Sleep Duration via Objective Measures.
    Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08485.
    PubMed         Abstract available


    Dis Colon Rectum

  6. ALIPOURIANI A, Yalamarthi N, Sancheti H, Cohen BL, et al
    A Propensity Score-Matched Analysis of Single-Port vs. Multi-Port Laparoscopic Total Abdominal Colectomy with End Ileostomy for Medically Refractory Ulcerative Colitis.
    Dis Colon Rectum. 2024 Jun 3. doi: 10.1097/DCR.0000000000003359.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  7. OZTURK O, Celebi G, Duman UG, Kupcuk E, et al
    Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects.
    Eur J Gastroenterol Hepatol. 2024;36:890-896.
    PubMed         Abstract available


    Gut

  8. HONAP S, Jairath V, Sands BE, Dulai PS, et al
    Acute severe ulcerative colitis trials: the past, the present and the future.
    Gut. 2024 Jun 4:gutjnl-2024-332489. doi: 10.1136/gutjnl-2024-332489.
    PubMed         Abstract available

  9. LIN S, Wang J, Mukherjee PK, Mao R, et al
    Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis.
    Gut. 2024;73:1110-1123.
    PubMed         Abstract available


    Inflamm Bowel Dis

  10. WITTEK A, Steglich B, Casar C, Seiz O, et al
    A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2024;30:900-910.
    PubMed         Abstract available

  11. ABOUBAKR A, Lukin DJ
    Freeing Time and Reducing Costs: The Value of a Specialized Nursing Service in IBD.
    Inflamm Bowel Dis. 2024;30:1046-1047.
    PubMed        

  12. CHEN M, Wei S, Wu X, Xiang Z, et al
    2'-Hydroxycinnamaldehyde Alleviates Intestinal Inflammation by Attenuating Intestinal Mucosal Barrier Damage Via Directly Inhibiting STAT3.
    Inflamm Bowel Dis. 2024;30:992-1008.
    PubMed         Abstract available


  13. Correction to: Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study.
    Inflamm Bowel Dis. 2024 Jun 1:izae134. doi: 10.1093.
    PubMed        

  14. LEDDER O, Dolinger M, Dubinsky MC, Stein R, et al
    Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience.
    Inflamm Bowel Dis. 2024 Jun 3:izae112. doi: 10.1093.
    PubMed         Abstract available

  15. NIELSEN KR, Lophaven SN, Midjord J, Langholz E, et al
    Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020.
    Inflamm Bowel Dis. 2024 Jun 3:izae120. doi: 10.1093.
    PubMed         Abstract available

  16. FALLOON K, Dossaji Z, Mude P, Abushamma S, et al
    Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review.
    Inflamm Bowel Dis. 2024 Jun 5:izae114. doi: 10.1093.
    PubMed         Abstract available

  17. DAVIES JM, Teh JJ, Ewais T, Begun J, et al
    Does Improving Depression Symptoms in Young Adults With Inflammatory Bowel Disease Alter Their Microbiome?
    Inflamm Bowel Dis. 2024 Jun 5:izae121. doi: 10.1093.
    PubMed         Abstract available

  18. EISENSTEIN S
    Surgery in Crohn's Disease: Past Performance Does Predict Future Results.
    Inflamm Bowel Dis. 2024 Jun 6:izae110. doi: 10.1093.
    PubMed        

  19. JOSEPH A, Bachour SP, Shah R, El Halabi J, et al
    Postoperative Crohn's Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic Resection.
    Inflamm Bowel Dis. 2024 Jun 6:izae117. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  20. AHMAD H, Click B, Morris HL, Crawford JM, et al
    Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBD.
    J Clin Gastroenterol. 2024 May 22. doi: 10.1097/MCG.0000000000002015.
    PubMed         Abstract available


    J Crohns Colitis

  21. SUAREZ RG, Guruprasad N, Tata G, Zhang Z, et al
    Serum Metabolites Relate to Mucosal and Transmural Inflammation in Pediatric Crohn Disease.
    J Crohns Colitis. 2024 Jun 6:jjae085. doi: 10.1093.
    PubMed         Abstract available

  22. TAMBURINI FB, Tripathi A, Gold MP, Yang JC, et al
    Gut microbial species and endotypes associate with remission in ulcerative colitis patients treated with anti-TNF or anti-integrin therapy.
    J Crohns Colitis. 2024 Jun 5:jjae084. doi: 10.1093.
    PubMed         Abstract available

  23. GHOSH S, Feagan BG, Parra RS, Lopes S, et al
    Impact of upadacitinib induction and maintenance therapy on health-related quality of life, fatigue, and work productivity in patients with moderately-to-severely active Crohn's disease.
    J Crohns Colitis. 2024 Jun 5:jjae083. doi: 10.1093.
    PubMed         Abstract available

  24. ZHU F, Chen X, Qiu X, Guo W, et al
    Seeing Beyond the Surface: Superior performance of Ultrasound elastography over Milan ultrasound criteria in distinguishing fibrosis of ulcerative colitis.
    J Crohns Colitis. 2024 Jun 3:jjae081. doi: 10.1093.
    PubMed         Abstract available

  25. OGATA N, Maeda Y, Misawa M, Takenaka K, et al
    Artificial intelligence-assisted video colonoscopy for disease monitoring of ulcerative colitis: A prospective study.
    J Crohns Colitis. 2024 Jun 3:jjae080. doi: 10.1093.
    PubMed         Abstract available

  26. REVES J, Torres J
    Real-world Positioning and Effectiveness of First- and Second-Line Biological Therapy in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:787-789.
    PubMed        

  27. HASHIMOTO H, Takagi T, Asaeda K, Yasuda T, et al
    D-alanine Inhibits Murine Intestinal Inflammation by Suppressing IL-12 and IL-23 Production in Macrophages.
    J Crohns Colitis. 2024;18:908-919.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.